Ep. 2 Cardiogenic Shock Management: Latest Strategies and Innovations with Dr. Amir Kaki episode artwork

EPISODE · Sep 16, 2025 · 44 MIN

Ep. 2 Cardiogenic Shock Management: Latest Strategies and Innovations with Dr. Amir Kaki

from Backtable Cardiology · host BackTable Inc.

In 2024, the DanGer Shock trial changed cardiogenic shock guidelines and affected practice patterns internationally. This episode of the BackTable Cardiology Podcast explores tips, tricks, and best practices in utilizing Impella, ECMO, and national initiatives to most effectively treat patients with cardiogenic shock. Host Dr. Sameh Sayfo interviews Dr. Amir Kaki, a noted interventional cardiologist and Director of Mechanical Circulatory Support and Complex PCI at Henry Ford St. John Hospital in Detroit. --- SYNPOSIS The discussion centers on the advances in mechanical circulatory support devices like Impella and ECMO, their history, usage criteria, and impact on patient outcomes. Dr. Kaki details the landmark Detroit Cardiogenic Shock Initiative, the challenges surrounding ECMO use, and the critical implementation of the recent DanGer-SHOCK Trial in clinical practice. After outlining the history of interventions for cardiogenic shock and the significance of recent trials within the field, he emphasizes the necessity for contemporary cardiologists to be skilled in endovascular techniques. --- TIMESTAMPS 00:00 - Introduction02:12 - National Cardiogenic Shock Initiative06:23 - Shock 2 Trial07:48 - ECLS-SHOCK Trial and ECMO15:05 - DanGer Trial22:56 - Parameters for Impella RP vs Impella CP Use in Cardiogenic Shock29:39 - Impella Considerations: Placement, Limb Ischemia, Removal 37:56 - Modern Cardiogenic Shock: Overview and Resources40:16 - Conclusion --- RESOURCES The National Cardiogenic Shock Initiative:https://www.ahajournals.org/doi/10.1161/JAHA.123.031401 DanGer Shock Trial:https://www.acc.org/Latest-in-Cardiology/Clinical-Trials/2024/04/05/04/44/danger-shock Large-Bore Access Site Managementhttps://assets.bmctoday.net/citoday/pdfs/cit0719_SF2_Kaki.pdf Short-Term Mechanical Circulatory Support for Cardiogenic Shockhttps://scai.org/publications/ebooks/short-term-mechanical-circulatory-support-cardiogenic-shock Intraaortic Balloon Support for Myocardial Infarction with Cardiogenic Shockhttps://www.nejm.org/doi/full/10.1056/NEJMoa1208410 Extracorporeal Life Support in Infarct-Related Cardiogenic Shockhttps://www.nejm.org/doi/full/10.1056/NEJMoa2307227 Dr. Amir Kaki, MDhttps://www.heartteam.com/provider/amir-kaki-mdhttps://scai.org/about-us/scai-staff-listing/amir-kaki-md-fscai Dr. Sameh Sayfohttps://www.bswhealth.com/physician/sameh-sayfo

Episode metadata supplied by the publisher feed · Published Sep 16, 2025

Embed this episode

NOW PLAYING

Ep. 2 Cardiogenic Shock Management: Latest Strategies and Innovations with Dr. Amir Kaki

0:00 44:01

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

No similar episodes found.

ACC CardiaCast American College of Cardiology This occasional series from the American College of Cardiology offers the latest in clinical education and features an exploration of current research and interviews with cardiovascular experts. Global Trial Accelerators™: Fast-Tracking First-in-Human Trials, Anywhere Julio G. Martinez-Clark Hosted by bioaccess® CEO, Julio G. Martinez-Clark, the Global Trial Accelerators™ podcast delivers actionable insights for Medtech, Biopharma, and Radiopharma innovators battling lengthy timelines and costly delays. Each episode features candid conversations with clinical trial pioneers, regulatory strategists, and startup founders who’ve slashed 6–12 months off approvals by leveraging emerging regions like Latin America, Eastern Europe, and Australia.What You’ll Learn:Speed Secrets: How to secure ethics approval in 4–6 weeks (vs. 6+ months in US/EU) using harmonized pathways like MINSA (Panama), ALIMS (Serbia), and Australia’s CTN.Cost-to-Speed Hacks: Operational strategies to reduce trial budgets by 30% while maintaining FDA/EMA compliance.Global Patient Access: Leverage treatment-naive populations in cardiology, rare diseases, and advanced therapies across 50+ pre-vetted sites.Why Listen?<ul JACC This Week American College of Cardiology A weekly co-hosted podcast featuring JACC Editor-in-Chief Harlan M. Krumholz, MD, SM, FACC and JACC Senior Consulting Editor Carolyn S.P. Lam, MBBS, PhD, giving readers context on our weekly issues. Listen in as they break down the latest trends and share practical tips that are changing the way heart care works globally. ESC Cardio Talk European Society of Cardiology The ESC podcasts - regular recordings from the European Society of Cardiology.Hear renowned experts discuss cardiovascular advances relevant to daily practice.Check here regularly to stay up to date.You can also be interested in other ESC podcasts: EHRA Cardio Talk, HFA Cardio Talk and ESC TV Today. Check them out!

Frequently Asked Questions

How long is this episode of Backtable Cardiology?

This episode is 44 minutes long.

When was this Backtable Cardiology episode published?

This episode was published on September 16, 2025.

Can I download this Backtable Cardiology episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.
URL copied to clipboard!